Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AIG vs GSK✓SelectedUSD · GSKAIG vs GSK performance historyLatest closeAs of+0.23%11/20
Stock and ETF performance explorer

AIG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+60.4%
GSK return
+97.4%
Excess return
-37.0%
Maximum drawdown
-69.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-0.1%+0.4%+0.3%
7D-3.8%-5.3%+1.5%-1.7%
30D-2.5%-3.7%+1.1%-1.2%
3M+5.9%-7.3%+13.1%+8.8%
6M+3.5%-4.2%+7.7%+4.6%
YTD-5.1%+0.9%-5.9%-6.8%
1Y+7.9%+7.3%+0.6%+3.1%
3Y+32.4%+52.7%-20.4%+3.6%
5Y+62.6%+40.1%+22.5%+30.4%
All+60.4%+97.4%-37.0%+16.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling